Drug Programs - Search News

CDC, drug overdose

US overdose deaths fell again in 2025, but some worry about policy and drug supply changes

About 70,000 Americans died of drug overdoses last year — about 14% fewer than the previous year, according to preliminary government data.

· 14h · on MSN

US drug overdose deaths fell by nearly 27% in 2024, CDC report finds

· 1d

US Drug Overdose Deaths Dropped for Third Straight Year in 2025, CDC Data Shows

· 9h

Drug overdose deaths declined last year, except in these 8 states

For a third consecutive year, fatal drug overdose deaths have declined in the U.S., new data from the Centers for Disease Control and Prevention showed Wednesday.

· 12h

Oregon overdose deaths fall for second year; veterinary tranquilizer, other drugs on rise

· 1d

Overdose deaths fall for 3rd straight year amid a changing drug supply and funding cuts

New pancreatic cancer drug nearly doubles survival

In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

2dOpinion

Is the 340B Discount Drug Program Working?

Readers offer opposing views on whether the healthcare program is living up to its mission.

Newsmax on MSNOpinion

Trump puts drug pricing program fraudsters on notice

Trump Puts Drug Pricing Program Fraudsters on Notice

2dOpinion

Drug pricing program undermines independent medical practices in Mass. | Stephanie Henley

Community-based practices are under increasing pressure to sell or close due to the unintended consequences of a rapidly growing federal program. Proposed legislation would lock in a flawed system.

AOL

What to know about the AIDS Drug Assistance Program bill DeSantis signed

Ryan Franklin, a registered nurse with AHF Healthcare Center St. Petersburg, chants along with about 30 fellow supporters on Jan. 30 in St. Petersburg. The AIDS Healthcare Foundation held protests at the county health departments in Pinellas and in Orange ...

23don MSN

Medicare Delays Full Obesity-Drug Program Rollout After Insurers Push Back

Without big Medicare insurers, the future of program to cover popular obesity drugs had been in question.